Appendix B - PBS Items
PBS subsidised mental health-related prescription medication |
|
Code | Medication groups | Code | Medication subgroup |
N05 | Psycholeptics | | |
| | | |
N05A | Antipsychotics | N05AA | Phenothiazines with aliphatic side-chain |
| | N05AB | Phenothiazines with piperazine structure |
| | N05AC | Phenothiazines with piperidine structure |
| | N05AD | Butyrophenone derivatives |
| | N05AE | Indole derivatives |
| | N05AF | Thioxanthene derivatives |
| | N05AH | Diazepines, oxazepines, thiazepines and oxepines |
| | N05AL | Benzamides |
| | N05AX | Other antipsychotics |
| | | |
N05B | Anxiolytics | N05BA | Benzodiazepine derivatives |
| | | |
N05C | Hypnotics and Sedatives | N05CD | Benzodiazepine derivatives |
| | | |
N06 | Psychoanaleptics | | |
| | | |
N06A | Antidepressants | N06AA | Non-selective monoamine reuptake inhibitors |
| | N06AB | Selective serotonin reuptake inhibitors |
| | N06AF | Monoamine oxidase inhibitors, non-selective |
| | N06AG | Monoamine oxidase A inhibitors |
| | N06AX | Other antidepressants |
| | | |
N06B | Psychostimulants, agents used for ADHD and Nootopics | N06BA | Centrally acting sympathomimetics |
Descriptions of Medications
N05 Psycholeptics | A group of drugs that tranquillises (central nervous system depressants) |
Antipsychotics (N05A) | Drugs used to treat symptoms of psychosis (a severe mental disorder characterised by loss of contact with reality, delusions and hallucinations), common in conditions such as schizophrenia, mania and delusional disorder. |
Anxiolytics (N05B) | Drugs prescribed to treat symptoms of anxiety. |
Hypnotics and sedatives (N05C) | Hypnotic drugs are used to induce sleep and treat severe insomnia.
Sedative drugs are prescribed to reduce excitability or anxiety. |
| |
N06 Psychoanaleptics | A group of drugs that stimulates the mood (central nervous system stimulants) |
Antidepressants (N06A) | Drugs used to treat the symptoms of clinical depression. |
Psychostimulants and nootropics (N06B) | Agents used for attention-deficit hyperactivity disorder and to improve impaired cognitive abilities (nootropics). |
Source: Australian Institute of Health and Welfare, 2014, 'Medicare-subsidised mental health-related prescriptions',
viewed 13 August 2014, <
https://mhsa.aihw.gov.au/services/medicare/>